AG-120 in People With IDH1 Mutant Chondrosarcoma
This study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.
Chondrosarcoma|Chondrosarcoma, Grade 2|Chondrosarcoma, Grade 3|IDH1 Gene Mutation
DRUG: AG-120
Progression free survival, Progression free survival includes both disease progression (as defined by RECIST 1.1) and death from any cause, 16 weeks
This study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.